Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits.

[1]  J. Gold,et al.  Impact of embolization during coronary artery bypass grafting on outcome and length of stay. , 1997, The Annals of thoracic surgery.

[2]  A. Kuitunen,et al.  Cardiopulmonary bypass with heparin-coated circuits and reduced systemic anticoagulation. , 1997, The Annals of thoracic surgery.

[3]  M. Kanchuger,et al.  Adverse Cerebral Outcomes after Coronary Bypass Surgery , 1996 .

[4]  R. Shemin,et al.  Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: a prospective, randomized study. , 1996, The Annals of thoracic surgery.

[5]  W D White,et al.  Defining neuropsychological dysfunction after coronary artery bypass grafting. , 1996, The Annals of thoracic surgery.

[6]  E. Fosse,et al.  High and low heparin dose with heparin-coated cardiopulmonary bypass: activation of complement and granulocytes. , 1995, The Annals of thoracic surgery.

[7]  G. Tangen,et al.  Effects on coagulation and fibrinolysis with reduced versus full systemic heparinization and heparin-coated cardiopulmonary bypass. , 1995, Circulation.

[8]  G. Tangen,et al.  Completely heparinized cardiopulmonary bypass and reduced systemic heparin: clinical and hemostatic effects. , 1995, The Annals of thoracic surgery.

[9]  N. Cantelmo,et al.  Cerebral microembolism during carotid endarterectomy. , 1995, American journal of surgery.

[10]  C. Mazer,et al.  Cerebral microemboli during coronary artery bypass using different cardioplegia techniques. , 1995, The Annals of thoracic surgery.

[11]  R. E. Clark,et al.  Microemboli during coronary artery bypass grafting. Genesis and effect on outcome. , 1995, The Journal of thoracic and cardiovascular surgery.

[12]  M. Pasic,et al.  Risk and benefit of low systemic heparinization during open heart operations. , 1994, The Annals of thoracic surgery.

[13]  E. Fosse,et al.  Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. , 1994, The Annals of thoracic surgery.

[14]  B. Nilsson,et al.  Complement activation during cardiopulmonary bypass: effects of immobilized heparin. , 1994, The Annals of thoracic surgery.

[15]  V. Babikian,et al.  Clinical Correlates of High‐Intensity Transient Signals Detected on Transcranial Doppler Sonography in Patients With Cerebrovascular Disease , 1994, Stroke.

[16]  L. Edmunds.  Surface-bound heparin--panacea or peril? , 1994, The Annals of thoracic surgery.

[17]  L. Cohn,et al.  Single-clamp technique: an important adjunct to myocardial and cerebral protection in coronary operations. , 1994, The Annals of thoracic surgery.

[18]  T. Treasure,et al.  The Impact of Microemboli During Cardiopulmonary Bypass on Neuropsychological Functioning , 1994, Stroke.

[19]  W. Baumgartner,et al.  Heparin-coated bypass circuits reduce pulmonary injury. , 1993, The Annals of thoracic surgery.

[20]  W. van Oeveren,et al.  Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass. , 1993, The Annals of thoracic surgery.

[21]  W. van Oeveren,et al.  Heparin-coating of extracorporea circuits reduces thrombin formation in patients undergoing cardiopulmonary bypass , 1991 .

[22]  E. Blackstone,et al.  Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. , 1981, The New England journal of medicine.

[23]  J. Gold,et al.  Comparison of transcranial Doppler ultrasonography and transesophageal echocardiography to monitor emboli during coronary artery bypass surgery. , 1996, Stroke.

[24]  R. Colman,et al.  Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass. , 1996, The Journal of thoracic and cardiovascular surgery.